Most research labs can make cells that produce antibodies. The trick is making those antibodies in sufficient quantity and quality to use throughout clinical trials and for manufacturing scale-up.
Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. To meet patient needs, reliable and cost-effective ...
The optimization of processes for the development and manufacture of biopharmaceuticals is pivotal for producing quality products. The development and production of biologics can be a complex process.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results